2.
    发明专利
    未知

    公开(公告)号:IT1238072B

    公开(公告)日:1993-07-03

    申请号:IT1911290

    申请日:1990-01-19

    Applicant: SCLAVO SPA

    Abstract: New pharmaceutical compositions containing a calcitonin as active principle and suitable for oral administration in the form of perbuccal and sublingual tablets are described, in which the tive principle is homogenized with a mixture of solid excipients, said excipients consisting of a diluent, a lubricant, a disintegrating agent in the case of sublingual tablets, and a binder in the case of perbuccal tablets. Said compositions enable the same pattern of hematic levels to be obtained for the same unit dose as obtainable by conventional intramuscular administration.

    5.
    发明专利
    未知

    公开(公告)号:IT9019112D0

    公开(公告)日:1990-01-19

    申请号:IT1911290

    申请日:1990-01-19

    Applicant: SCLAVO SPA

    Abstract: New pharmaceutical compositions containing a calcitonin as active principle and suitable for oral administration in the form of perbuccal and sublingual tablets are described, in which the tive principle is homogenized with a mixture of solid excipients, said excipients consisting of a diluent, a lubricant, a disintegrating agent in the case of sublingual tablets, and a binder in the case of perbuccal tablets. Said compositions enable the same pattern of hematic levels to be obtained for the same unit dose as obtainable by conventional intramuscular administration.

    6.
    发明专利
    未知

    公开(公告)号:IT8922410D0

    公开(公告)日:1989-11-16

    申请号:IT2241089

    申请日:1989-11-16

    Applicant: SCLAVO SPA

    Abstract: New formulations are described containing a calcitonin as active principle and suitable for rectal administration in the form of soft gelatin capsules, in which the active principle, possibly mixed with a stabilizer, is dispersed in a liquid vehicle consisting of a polyethyleneglycol or a mixture of polyethyleneglycols of different molecular weight which has the consistency of a homogeneous fluid at ambient temperature, and possibly a C2-C6 alcohol with at least 2 hydroxyl groups, and present in a weight quantity of less than 15%. Said formulations, which contain no absorption adjuvant, enable the same pattern of hematic levels to be obtained as obtainable by conventional intramuscular administration, for equal unit dosages. Moreover, the absence of water makes said formulations highly stable.

    7.
    发明专利
    未知

    公开(公告)号:IT1237197B

    公开(公告)日:1993-05-26

    申请号:IT2241089

    申请日:1989-11-16

    Applicant: SCLAVO SPA

    Abstract: New formulations are described containing a calcitonin as active principle and suitable for rectal administration in the form of soft gelatin capsules, in which the active principle, possibly mixed with a stabilizer, is dispersed in a liquid vehicle consisting of a polyethyleneglycol or a mixture of polyethyleneglycols of different molecular weight which has the consistency of a homogeneous fluid at ambient temperature, and possibly a C2-C6 alcohol with at least 2 hydroxyl groups, and present in a weight quantity of less than 15%. Said formulations, which contain no absorption adjuvant, enable the same pattern of hematic levels to be obtained as obtainable by conventional intramuscular administration, for equal unit dosages. Moreover, the absence of water makes said formulations highly stable.

    10.
    发明专利
    未知

    公开(公告)号:AT69384T

    公开(公告)日:1991-11-15

    申请号:AT88114598

    申请日:1988-09-07

    Applicant: SCLAVO SPA

    Abstract: New compositions containing a calcitonin as the active ingredient are described which are suitable for the intrarectal administration as soft gelatin capsules or microenemas, wherein the active principle, optionally admixed with a stabilizer, is dissolved in a liquid vehicle consisting of : a) at least 70 % by weight of a polyethylene or a polypropylene glycol or a mixture of polyethylene or polypropylene glycols with different molecular weights, having the consistency of a homogeneous fluid at room temperature, and b) less than 15 % by weight of a buffer in a pH range of from 4.5 to 6.5, and optionally c) less than 15 % by weight of an alcohol of 2 to 6 carbon atoms containing two or more hydroxy groups. The new compositions, which do not contain any absorption aid, give calcitonin plasma levels comparable to a conventional intramuscular administration.

Patent Agency Ranking